Dry powder cationic lipopolymeric nanomicelle inhalation for targeted delivery of antitubercular drug to alveolar macrophage
Mithun Varghese Vadakkan,1 K Annapoorna,2 KC Sivakumar,3 Sathish Mundayoor,2 GS Vinod Kumar1 1Chemical Biology, 2Mycobacterium Research Group, 3Bioinformatics Facility, Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram, Kerala, India Abstract: Excipients having self-assembling properties are...
Enregistré dans:
Auteurs principaux: | Vadakkan MV, Annapoorna K, Sivakumar KC, Mundayoor S, Kumar GSV |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2013
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/99d849c436d14de1bca156f03ed3e3c6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Understanding the Importance of Capsules in Dry Powder Inhalers
par: Francesca Buttini, et autres
Publié: (2021) -
Nanosized rods agglomerates as a new approach for formulation of a dry powder inhaler
par: HF Salem, et autres
Publié: (2011) -
New inhalation-optimized itraconazole nanoparticle-based dry powders for the treatment of invasive pulmonary aspergillosis
par: Duret C, et autres
Publié: (2012) -
Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats
par: Li Z, et autres
Publié: (2016) -
SYNTHESIS AND ANTITUBERCULAR ACTIVITY OF PYRIDAZINONE DERIVATIVES
par: HUSAIN,ASIF, et autres
Publié: (2011)